Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial.

@article{Bhutda2013FiveYC,
  title={Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial.},
  author={Girish Bhutda and Vikas Devkaran Singh Deo},
  journal={Acta odontologica Scandinavica},
  year={2013},
  volume={71 3-4},
  pages={764-70}
}
INTRODUCTION Emdogain® represents an extracellular matrix derivative that controls and promotes periodontal regeneration. Several studies have demonstrated that the treatment of periodontal defects with Emdogain® leads to improvements in clinical parameters. However, long-time clinical trials establishing clinical usefulness of Emdogain® are scarce. Therefore, the present randomized split mouth, controlled study was undertaken to evaluate the effectiveness of Emdogain® as an adjunct to open… CONTINUE READING